Mona Cayton

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical businesses, like the makers of Xarelto, have a duty to ensure that their drugs are reasonably secure for use - and failure to complete so may be grounds for compensation. Our lawyers are working difficult to obtain these hurt by the drug the compensation they're entitled to. Whilst bleeding is actually a typical complication related with anticoagulants, it has been alleged that Xarelto is a lot more harmful than standard blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This indicates that, inside the event of an emergency, individuals might be at danger for irreversible bleeding issues, which includes life-threatening internal and gastrointestinal hemorrhaging. In the event you or perhaps a loved one particular suffered a significant bleeding occasion following taking Xarelto, you may have legal recourse. For a lot more info, make contact with us these days to have your case reviewed, free of charge. Compensation Possibilities xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future health-related bills, lost wages, discomfort and suffering and, in situations of death, funeral costs. Furthermore, they may be seeking punitive damages, which are generally awarded to punish the defendant and deter other organizations from acting similarly. Why Are Lawsuits Being Filed? Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug. In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging: The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors. The makers of the drug continue to market Xarelto as a protected anticoagulant option. Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication. Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event. Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting. Visit this page for far more data on the alleged health risks of Xarelto. Multidistrict Litigation Trial Dates Set The attorneys within the Complex Litigation Group have filed lawsuits on front page behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.